Subscribe

Usha Iyer, Cambridge BioMarketing

Articles by Usha Iyer, Cambridge BioMarketing

Drug development in rare diseases

ByBy Sam Falsetti,Usha Iyer, Cambridge BioMarketing

September 7th 2017

Latest Updated Articles

Drug development in rare diseases
Published: September 7th 2017 | Updated:

Trending on Pharmaceutical Commerce

It’s Official: CMS Unveils Big Price Cuts for 15 High-Cost Medicare Drugs in Latest IRA Negotiation Round

Medicare Set to Unveil Prices for 15 High-Cost Drugs

What Sets True DSCSA Readiness Apart?

The New Realities of DSCSA Compliance

The Unwritten Requirement for CNPVs

© 2025 MJH Life Sciences^®

All rights reserved.